Drug interactions
Denosumab + Meningococcal group b vaccine
Severity: Minor
Denosumab and Meningococcal group b vaccine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Meningococcal B vaccine is non-live, so it is safe to give, but patients with altered immunity may mount a weaker response. Denosumab is not a strong immunosuppressant, so any effect on vaccine response is theoretical.
What this interaction means in plain words
Denosumab and Meningococcal group b vaccine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Possible reduced vaccine immunogenicity from immune modulation; not established for denosumab.
What to do
Vaccinate per schedule without delaying denosumab. Consider checking vaccine response in patients who are also on other immunosuppressants.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Denosumab and Meningococcal group b vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Denosumab
- Abatacept + Denosumab Moderate
- Adalimumab + Denosumab Moderate
- Alefacept + Denosumab Moderate
- Alemtuzumab + Denosumab Moderate
- Anakinra + Denosumab Moderate
- Azacitidine + Denosumab Moderate
Frequently asked questions
Can I take Denosumab with Meningococcal group b vaccine?
MediHelp rates the interaction as minor. Denosumab and Meningococcal group b vaccine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Meningococcal B vaccine is non-live, so it is safe to give, but patients with altered immunity may mount a weaker response. Denosumab is not a strong immunosuppressant, so any effect on vaccine response is theoretical.
How serious is the interaction between Denosumab and Meningococcal group b vaccine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate per schedule without delaying denosumab. Consider checking vaccine response in patients who are also on other immunosuppressants.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.